Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.
Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.
复制标题
DOI:
10.4049/jimmunol.1302884
复制
发表时间:
2014-03-15
期刊:
影响因子:
--
通讯作者:
Bielekova B
中科院分区:
文献类型:
--
作者:
Han S;Lin YC;Wu T;Salgado AD;Mexhitaj I;Wuest SC;Romm E;Ohayon J;Goldbach-Mansky R;Vanderver A;Marques A;Toro C;Williamson P;Cortese I;Bielekova B
We performed unbiased, comprehensive immunophenotyping of cerebrospinal fluid (CSF) and blood leukocytes in 221 subjects referred for the diagnostic work-up of neuroimmunological disorders in order to obtain insight about disease-specific phenotypes of intrathecal immune responses. Quantification of 14 different immune cell subsets, coupled with the assessment of their activation status, revealed physiological differences between intrathecal and systemic immunity, irrespective of final diagnosis. Our data are consistent with a model, where the central nervous system shapes intrathecal immune responses to provide effective protection against persistent, especially by memory T cells, plasmacytoid dendritic cells and CD56bright NK cells. Our data also argue that CSF immune cells do not simply reflect cells recruited from the periphery. Instead, they represent a mixture of cells that are recruited from the blood, have been activated intrathecally and leave the CNS after performing effector functions. Diagnosis-specific differences provide mechanistic insight into the disease process in the defined subtypes of multiple sclerosis (MS), neonatal onset multisystem inflammatory disease and Aicardi-Goutieres syndrome. This analysis also determined that secondary-progressive MS patients are immunologically closer to relapsing-remitting patients as compared to patients with primary-progressive MS. Because CSF immunophenotyping captures the biology of the intrathecal inflammatory processes, it has the potential to guide optimal selection of immunomodulatory therapies in individual patients and monitor their efficacy. Our study adds to the increasing number of publications that demonstrate poor correlation between systemic and intrathecal inflammatory biomarkers in patients with neuroimmunological diseases and stresses the importance of studying immune responses directly in the intrathecal compartment.
登录
查看更多内容
影响因子:
64.8
作者:
Kim, Jiyun V.;Kang, Silvia S.;Dustin, Michael L.;McGavern, Dorian B.
通讯作者:
McGavern, Dorian B.
影响因子:
3.7
作者:
Fritzsching B;Haas J;König F;Kunz P;Fritzsching E;Pöschl J;Krammer PH;Brück W;Suri-Payer E;Wildemann B
通讯作者:
Wildemann B
影响因子:
5.4
作者:
Donaghy, Heather;Bosnjak, Lidija;Cunningham, Anthony L.
通讯作者:
Cunningham, Anthony L.
DOI:
10.1073/pnas.0601335103
发表时间:
2006-04-11
影响因子:
11.1
作者:
Bielekova, B;Catalfamo, M;Martin, R
通讯作者:
Martin, R
影响因子:
15.8
作者:
Ioannidis, JPA
通讯作者:
Ioannidis, JPA